CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,373,577 | -31.5% | 327,042 | -1.9% | 0.00% | – |
| Q4 2022 | $2,004,479 | -7.3% | 333,524 | -10.2% | 0.00% | -100.0% |
| Q3 2022 | $2,162,000 | -26.8% | 371,489 | -24.9% | 0.00% | 0.0% |
| Q2 2022 | $2,954,000 | +261.1% | 494,831 | +182.7% | 0.00% | – |
| Q1 2022 | $818,000 | +1158.5% | 175,057 | +564.8% | 0.00% | – |
| Q4 2021 | $65,000 | -16.7% | 26,332 | 0.0% | 0.00% | – |
| Q3 2021 | $78,000 | +18.2% | 26,332 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | -14.3% | 26,332 | 0.0% | 0.00% | – |
| Q1 2021 | $77,000 | -17.2% | 26,332 | -9.1% | 0.00% | – |
| Q4 2020 | $93,000 | -41.5% | 28,970 | -82.4% | 0.00% | – |
| Q1 2019 | $159,000 | +43.2% | 164,695 | +9.3% | 0.00% | – |
| Q4 2018 | $111,000 | -65.8% | 150,673 | +0.0% | 0.00% | – |
| Q3 2018 | $325,000 | -56.7% | 150,671 | 0.0% | 0.00% | – |
| Q2 2018 | $750,000 | +288.6% | 150,671 | +203.7% | 0.00% | – |
| Q1 2018 | $193,000 | +232.8% | 49,616 | +129.2% | 0.00% | – |
| Q4 2017 | $58,000 | -15.9% | 21,645 | +0.0% | 0.00% | – |
| Q3 2017 | $69,000 | -4.2% | 21,643 | 0.0% | 0.00% | – |
| Q2 2017 | $72,000 | -20.9% | 21,643 | 0.0% | 0.00% | – |
| Q1 2017 | $91,000 | – | 21,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|